Generics in France, MarketLine

  • August 2013
  • -
  • MarketLine
  • -
  • 33 pages

Summary

Table of Contents

Generics Market Overview in France


Introduction

Generics in France industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the France generics market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

*The French generics market had total revenues of $4.5bn in 2012, representing a compound annual growth rate (CAGR) of 7.2% between 2008 and 2012.

*Market consumption volume increased with a CAGR of 10.1% between 2008-2012, to reach a total of 42.7% of total pharma volume in 2012.

*The performance of the market is forecast to decelerate, with an anticipated CAGR of 5.2% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $5.8bn by the end of 2017.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in France

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in France

Leading company profiles reveal details of key generics market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the France generics market with five year forecasts by both value and volume

Macroeconomic indicators provide insight into general trends within the France economy

Key Questions Answered

What was the size of the France generics market by value in 2012?

What will be the size of the France generics market in 2017?

What factors are affecting the strength of competition in the France generics market?

How has the market performed over the last five years?

What are the main segments that make up France's generics market?

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

Get This Report

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Patent Cliff and the Future of Generics in Asia : Trends that will Impact the Market in the Short Term

Patent Cliff and the Future of Generics in Asia : Trends that will Impact the Market in the Short Term

  • $ 3 500
  • Industry report
  • December 2014
  • by Frost & Sullivan

Executive Summary •The generic drug manufacturers in Asia have started looking beyond patent cliff to drive growth. As less drugs are expected to go off patent in 2015-2017, the manufacturers are adopting ...

Generics: World Market Overview (Market size, Segmentation and Trends Analysis)

Generics: World Market Overview (Market size, Segmentation and Trends Analysis)

  • $ 1 495
  • Industry report
  • December 2014
  • by MarketLine

It includes detailed data on industry size and sector ation, textual analysis of the key trends and competitive landscape, and profiles of the leading firms . This incisive report provides expert analysis ...

Generic Pharmaceuticals Global - Industry Report

Generic Pharmaceuticals Global - Industry Report

  • $ 1 668
  • Industry report
  • January 2015
  • by Plimsoll Publishing Ltd UK

Plimsoll's GENERIC PHARMACEUTICALS (Global) analysis is the most definitive and accurate study of the GENERIC PHARMACEUTICALS (Global) sector in 2013. The report is split into two sections and uses both ...

Global Generics, Marketline

December 2014 $ 350

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.